Foundation for Liver Research: Clinical Trials

31 trials sponsored by Foundation for Liver Research, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

26 completed, 3 unknown, 1 terminated, 1 withdrawn. 9 Phase 3, 7 Phase 4, 5 Not applicable, 5 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 39Completed 8, Terminated 1
Phase 47Completed 6, Withdrawn 1
Not applicable5Completed 4, Unknown 1
Phase 25Completed 5
Phase 12Completed 2

Follow Foundation for Liver Research: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Precision Nutrition to Improve Cardiometabolic Health With Dietary (Poly)Phenols
Personalized Dietary Plan, Oral (Poly)phenol Challenge Test (OPCT), General Dietary Advice - Individual Variability in (Poly)Phenol Metabolism, Cardiometabolic Health
Not applicableUnknownUniversity of Parma3302024-04-222024-05-10
EndoRotor® Ablation of Barrett's Esophagus: Safety and Feasibility Study
The EndoRotor® - Barretts Esophagus With Dysplasia
Not applicableCompletedFoundation for Liver Research302017-01-272020-01-29
Comparing a 25G EUS Fine Needle Aspiration (FNA) Device With a 20G EUS
25G FNA needle, 20G ProCore FNB needle - Pancreatic Masses, Lymph Nodes
Not applicableCompletedFoundation for Liver Research6152015-02-012021-08-23
Efficacy and Feasibility of Combining FOLFIRINOX and Stereotactic Radiotherapy for Patients With Irresectable Locally Advanced Pancreatic Cancer.
stereotactic radiotherapy - Pancreatic Neoplasms
Not applicableCompletedFoundation for Liver Research532014-12-022020-07-29
Swiss Liver Venous Thrombosis Study
Observational Study
UnknownInsel Gruppe AG, University Hospital Bern5002014-03-182023-03-15
Effect of ASV and DCV Therapy on the Quality of Immune Status in Chronic HCV Patients
Daclatasvir, asunaprevir - Chronic Hepatitis C
Phase 3CompletedFoundation for Liver Research122014-02-012015-10-19
Immune Response in Patients With Hepatitis B and C Infection
Hepatitis B, Hepatitis C
UnknownMid and South Essex NHS Foundation Trust1502013-08-012024-01-12
Fully Covered or Partially Covered Stents in Malignant Esophageal Strictures
Partially covered SEMS, Fully covered SEMS - Esophageal Cancer, Esophageal Stenosis
Not applicableCompletedFoundation for Liver Research982012-07-012019-10-03
Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHB
PegIFN alfa-2b - Chronic Hepatitis B
Phase 4CompletedFoundation for Liver Research822012-06-012019-01-04
PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients
Peginterferon alfa-2a, Nucleos(t)ide analogue - Chronic Hepatitis B
Phase 4CompletedFoundation for Liver Research902012-05-252019-11-08
Effect of Teleprevir in Triple Therapy on Intrahepatic Immunological Mechanisms
Chronic Hepatitis C
CompletedFoundation for Liver Research202012-05-012015-03-11
Enzyme Suppletion in Exocrine Pancreatic Dysfunction
Panzytrat 25.000 FIP-E units of Lipase - Chronic Pancreatitis, Exocrine Pancreatic Insufficiency
Phase 4CompletedFoundation for Liver Research102011-10-012015-03-11
Pancreatic Enzyme Suppletion in Pancreatic Cancer
Timing of start treatment with pancreatic enzymes - Adenocarcinoma of the Pancreas, Normal Pancreatic Exocrine Function
Phase 4WithdrawnFoundation for Liver Research2011-10-012013-02-22
Study Comparing in Livertransplantation Recipients With Tacrolimus Alone Versus Tacrolimus&Sirolimus
Tacrolimus and Sirolimus, Tacrolimus - Liver Disease
Phase 4CompletedFoundation for Liver Research1962011-02-072022-03-18
Entecavir for Chronic Hepatitis B
Entecavir - Entecavir for Chronic Hepatitis B Patients
CompletedFoundation for Liver Research4182010-11-012011-03-25
Genetic Study of Peginterferon Treatment in Hepatitis B Patients: The GIANT-B Study
Chronic Hepatitis B
CompletedFoundation for Liver Research13502010-05-012015-08-14
Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis B
pegylated interferon a-2a, Entecavir - Chronic Hepatitis B
Phase 4CompletedFoundation for Liver Research1842009-08-012014-03-28
PEG-IFN in HBV Patients With Incomplete Response to NA
Nucleos(t)ide analogue treatment with a peginterferon add-on strategy, Nucleos(t)ide analogue treatment - Chronic Hepatitis B
Phase 4CompletedFoundation for Liver Research112009-04-012013-04-19
Colesevelam Versus Placebo in Cholestatic Pruritus
colesevelam, placebo - Chronic Liver Disease
Phase 2 / Phase 3CompletedFoundation for Liver Research382008-09-012012-12-18
Adalimumab in Combination With Ciprofloxacin/Placebo Treatment of Perianal Fistulas in Crohn's
adalimumab, ciprofloxacin - Crohn's Disease With Perianal Fistulas
Phase 3CompletedFoundation for Liver Research762008-09-012012-04-17

Showing 20 of 31. Sign in to see all of them.

Conditions studied

Hepatitis C (8)  ·  Hepatitis B, Chronic (7)  ·  Hepatitis B (6)  ·  Bronchiolitis Obliterans Syndrome (5)  ·  Hepatitis C, Chronic (5)  ·  Crohn Disease (1)  ·  Esophageal Neoplasms (1)  ·  Esophageal Stenosis (1)  ·  Exocrine Pancreatic Insufficiency (1)  ·  Liver Diseases (1)  ·  Obesity (1)  ·  Pancreatic Neoplasms (1)  ·  Pancreatitis, Chronic (1)  ·  Pruritus (1)  ·  RNA Virus Infections (1)

Interventions

Ribavirin (5)  ·  peginterferon alfa-2a (4)  ·  entecavir (3)  ·  Interferon alpha-2 (2)  ·  Introns (2)  ·  KRN 7000 (2)  ·  peginterferon alfa-2b (2)  ·  Adalimumab (1)  ·  Biopsy, Fine-Needle (1)  ·  Ciprofloxacin (1)  ·  Colesevelam Hydrochloride (1)  ·  Escitalopram (1)  ·  Radiosurgery (1)  ·  Sirolimus (1)  ·  Tacrolimus (1)

Countries

Netherlands (28)  ·  China (2)  ·  Italy (2)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Israel (1)  ·  Japan (1)  ·  Poland (1)  ·  Romania (1)  ·  Spain (1)  ·  Sweden (1)  ·  Switzerland (1)  ·  Turkey (Türkiye) (1)

Top investigators

Marco Bruno, MD, PhD (2)  ·  R.J. de Knegt, MD, PhD (2)  ·  A. Boonstra, PhD (1)  ·  Andrea De Gottardi, Prof. Dr. med. (1)  ·  Arjun D. Koch, MD, PhD (1)  ·  C.J. van der Woude, MD PhD (1)  ·  Carin MJ van Nieuwkerk, MD, PhD (1)  ·  Djuna L Cahen, MD, PhD (1)  ·  Gavin Wright, MBBS MRCP (1)

Results publications

PMID 35599306, PMID 35941076, PMID 30689258, PMID 33222190, PMID 19584831, PMID 20683930, PMID 23525574, PMID 25348661, PMID 26223768, PMID 28329061, PMID 29895072, PMID 30367877, PMID 30715261, PMID 31330556, PMID 31891135, PMID 31912157, PMID 34521118

NIH funding

2014 (1)